NCT06958835View on ClinicalTrials.gov

Linezolid Plus Standard of Care

NANot yet recruitingINTERVENTIONAL
Enrollment

606

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
Interventions
DRUG

Linezolid 600 mg

linezolid 600 mg tablets (twice a day for 5 days)

DRUG

Placebo

Placebo tablets (twice a day for 5 days)

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT06958835 - Linezolid Plus Standard of Care | Biotech Hunter | Biotech Hunter